Charles Schwab’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-853,475
| Closed | -$20.2M | – | 3538 |
|
2023
Q4 | $20.2M | Buy |
853,475
+54,920
| +7% | +$1.3M | 0.01% | 1592 |
|
2023
Q3 | $11.9M | Buy |
798,555
+533,821
| +202% | +$7.96M | ﹤0.01% | 1823 |
|
2023
Q2 | $2.9M | Buy |
264,734
+226,254
| +588% | +$2.48M | ﹤0.01% | 2437 |
|
2023
Q1 | $336K | Buy |
38,480
+3,914
| +11% | +$34.1K | ﹤0.01% | 3059 |
|
2022
Q4 | $217K | Hold |
34,566
| – | – | ﹤0.01% | 3170 |
|
2022
Q3 | $121K | Sell |
34,566
-14,046
| -29% | -$49.2K | ﹤0.01% | 3208 |
|
2022
Q2 | $144K | Sell |
48,612
-190,603
| -80% | -$565K | ﹤0.01% | 3262 |
|
2022
Q1 | $744K | Buy |
239,215
+59,256
| +33% | +$184K | ﹤0.01% | 2967 |
|
2021
Q4 | $609K | Buy |
179,959
+6,000
| +3% | +$20.3K | ﹤0.01% | 3088 |
|
2021
Q3 | $635K | Sell |
173,959
-357,375
| -67% | -$1.3M | ﹤0.01% | 3060 |
|
2021
Q2 | $2.32M | Sell |
531,334
-7,780
| -1% | -$33.9K | ﹤0.01% | 2664 |
|
2021
Q1 | $2.45M | Buy |
539,114
+19,421
| +4% | +$88.2K | ﹤0.01% | 2602 |
|
2020
Q4 | $2.98M | Sell |
519,693
-725
| -0.1% | -$4.16K | ﹤0.01% | 2460 |
|
2020
Q3 | $3.77M | Buy |
520,418
+84,488
| +19% | +$612K | ﹤0.01% | 2220 |
|
2020
Q2 | $1.52M | Buy |
435,930
+60,665
| +16% | +$212K | ﹤0.01% | 2507 |
|
2020
Q1 | $556K | Buy |
375,265
+5,561
| +2% | +$8.24K | ﹤0.01% | 2676 |
|
2019
Q4 | $725K | Sell |
369,704
-21,394
| -5% | -$42K | ﹤0.01% | 2698 |
|
2019
Q3 | $2M | Sell |
391,098
-2,025
| -0.5% | -$10.4K | ﹤0.01% | 2376 |
|
2019
Q2 | $2.82M | Buy |
393,123
+28,205
| +8% | +$202K | ﹤0.01% | 2241 |
|
2019
Q1 | $4.85M | Buy |
364,918
+41,319
| +13% | +$549K | ﹤0.01% | 1990 |
|
2018
Q4 | $2.55M | Sell |
323,599
-2,052
| -0.6% | -$16.2K | ﹤0.01% | 2237 |
|
2018
Q3 | $3.61M | Buy |
325,651
+195,486
| +150% | +$2.17M | ﹤0.01% | 2212 |
|
2018
Q2 | $1.75M | Buy |
130,165
+109,800
| +539% | +$1.47M | ﹤0.01% | 2416 |
|
2018
Q1 | $265K | Buy |
20,365
+7,900
| +63% | +$103K | ﹤0.01% | 2911 |
|
2017
Q4 | $115K | Buy |
+12,465
| New | +$115K | ﹤0.01% | 3024 |
|